PA
SWTX

Perceptive Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Perceptive Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-692,263
Closed -$22.2M – 117
2024
Q3 		$22.2M Sell
692,263
-960,699
-58% -$35.9M 0.47% 54
2024
Q2 		$62.3M Sell
1,652,962
-609,500
-27% -$25.7M 1.5% 18
2024
Q1 		$111M Buy
2,262,462
+305,216
+16% +$14.1M 1.95% 14
2023
Q4 		$71.4M Buy
1,957,246
+436,830
+29% +$11.4M 1.59% 18
2023
Q3 		$35.2M Sell
1,520,416
-17,015
-1% -$465K 1.17% 27
2023
Q2 		$40.3M Sell
1,537,431
-541,921
-26% -$14.2M 1.17% 28
2023
Q1 		$53.5M Sell
2,079,352
-538,339
-21% -$15.7M 1.58% 19
2022
Q4 		$68.1M Sell
2,617,691
-852,872
-25% -$21M 1.91% 18
2022
Q3 		$99M Sell
3,470,563
-396,883
-10% -$11.4M 2.87% 10
2022
Q2 		$95.2M Sell
3,867,446
-660,547
-15% -$24.2M 2.98% 9
2022
Q1 		$256M Sell
4,527,993
-321,919
-7% -$18.4M 5.12% 3
2021
Q4 		$301M Hold
4,849,912
– – 4.63% 5
2021
Q3 		$308M Hold
4,849,912
– – 4.47% 4
2021
Q2 		$400M Hold
4,849,912
– – 5.19% 3
2021
Q1 		$357M Buy
4,849,912
+672,191
+16% +$52.6M 4.51% 4
2020
Q4 		$303M Buy
4,177,721
+696,573
+20% +$44.8M 3.25% 7
2020
Q3 		$166M Sell
3,481,148
-33,210
-0.9% -$1.41M 2.42% 10
2020
Q2 		$148M Buy
3,514,358
+30,000
+0.9% +$1.07M 2.39% 13
2020
Q1 		$94.1M Buy
3,484,358
+146,836
+4% +$4.79M 2.45% 10
2019
Q4 		$128M Buy
3,337,522
+120,000
+4% +$2.81M 2.55% 12
2019
Q3 		$69.8M Buy
+3,217,522
New +$76.1M 1.88% 15

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Perceptive Advisors's SWTX Position: Q4 2024 in Review

Perceptive Advisors sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 692,263 shares — an estimated $22.2M sold.

Perceptive Advisors first reported a position in SWTX in Q3 2019 and held it in 21 quarters. The position peaked at $400M in Q2 2021. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.

  • Perceptive Advisors reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Perceptive Advisors sold 692,263 SpringWorks Therapeutics shares in Q4 2024, an estimated $22.2M.
  • Perceptive Advisors first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 21 quarters.
  • Perceptive Advisors's SpringWorks Therapeutics position peaked at $400M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.

Based on Perceptive Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.